Global Autoimmune Disease Diagnostics Market 2021

January 2022 | 13 pages | ID: GA3E5607DF76EN
StrategyHelix Inc

Abstracts

An autoimmune disease is a condition arising from an abnormal immune response to a functioning body part. There are around 80 different autoimmune disorders ranging in severity from mild to disabling, depending on which system of the body is under attack and to what degree. The global autoimmune disease diagnostics market is poised to grow by US$ 1,541 million during 2021-2027, progressing at a CAGR of 5.1% during the forecast period, according to data and analytics company StrategyHelix. Growing patient awareness levels concerning autoimmune diseases, presence of favorable government initiatives, improved laboratory automation, rise in the geriatric population and growing prevalence of obesity, type 1 diabetes and other chronic diseases are expected to boost the market growth in the coming years.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for autoimmune disease diagnostics. The global autoimmune disease diagnostics market is segmented on the basis of type, gender, technology, and region. By type, the global autoimmune disease diagnostics market has been segmented into systemic autoimmune disease diagnostics, localized autoimmune disease diagnostics. The localized autoimmune disease diagnostics segment was the largest contributor to the global autoimmune disease diagnostics market in 2020. Based upon gender, the global autoimmune disease diagnostics market is categorized into female, male. According to the research, the female segment had the largest share in the global autoimmune disease diagnostics market. On the basis of technology, the global autoimmune disease diagnostics market has been segmented into enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence (IIF), immunoblot, multiplex immunoassays, others. Geographically, the global autoimmune disease diagnostics market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The systemic autoimmune disease diagnostics market is further segmented into rheumatoid arthritis, psoriasis/psoriatic arthritis, systemic lupus erythematosus, multiple sclerosis, and others. The rheumatoid arthritis segment is estimated to account for the largest share of the global autoimmune disease diagnostics market. Furthermore, the localized autoimmune disease diagnostics market has been categorized into inflammatory bowel disease, type 1 diabetes, thyroid, and others. The thyroid segment held the largest share of the global autoimmune disease diagnostics market in 2020 and is anticipated to hold its share during the forecast period.

The global autoimmune disease diagnostics market is highly competitive. The autoimmune disease diagnostics market is dominated by key players, which are Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMerieux Inc., Bio-Rad AbD Serotec Limited, Bristol Myers Squibb (BMS), EUROIMMUN AG (PerkinElmer Inc.), F. Hoffmann-La Roche AG, Immuno Concepts Inc., INOVA Diagnostics Inc., Siemens Healthineers AG, SQI Diagnostics Inc., Thermo Fisher Scientific Inc., Trinity Biotech plc (IMMCO Diagnostics Inc).

Report Scope
Type: systemic autoimmune disease diagnostics, localized autoimmune disease diagnostics
Gender: female, male
Technology: enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence (IIF), immunoblot, multiplex immunoassays, others
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders
Get a comprehensive picture of the global autoimmune disease diagnostics market
Pinpoint growth sectors and trends for investment

Contents

PART 1. INTRODUCTION

Scope of the study
Study period
Geographical scope
Research methodology

PART 2. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET OVERVIEW

PART 3. MARKET BREAKDOWN BY TYPE

Systemic autoimmune disease diagnostics
Localized autoimmune disease diagnostics

PART 4. MARKET BREAKDOWN BY GENDER

Female
Male

PART 5. MARKET BREAKDOWN BY TECHNOLOGY

Enzyme-linked immunosorbent assay (ELISA)
Indirect immunofluorescence (IIF)
Immunoblot
Multiplex immunoassays
Others

PART 6. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 7. KEY COMPANIES

Abbott Laboratories
Beckman Coulter Inc. (Danaher Corporation)
Becton, Dickinson and Company
bioMerieux, Inc.
Bio-Rad AbD Serotec Limited
Bristol Myers Squibb (BMS)
EUROIMMUN AG (PerkinElmer, Inc.)
F. Hoffmann-La Roche AG
Immuno Concepts, Inc.
INOVA Diagnostics, Inc.
Siemens Healthineers AG
SQI Diagnostics, Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech plc (IMMCO Diagnostics Inc)
About StrategyHelix
Disclaimer